3 Health Care Trends for 2023 : Understanding the current situation of access to care and other patients’ booking preferences may provide a sense of hope for 2023, as many individuals are getting ready to make health and wellness plans in the new year. Using data from appointment booking patterns […]
Hitesh
Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio
The silicone extrusion facility Medical Elastomer Development, Inc. (“MED”), owned by Q Holding, a 3i portfolio business, has been acquired by Sanisure, a prominent, vertically-integrated participant in the single-use bioprocessing technology market. This cutting-edge plant, which is situated in Twinsburg, Ohio, provides services to numerous market leaders in the medical […]
National Council on Aging Launches Coordinated Effort to Promote COVID and Flu Vaccinations
The U.S. Administration for Community Living has awarded a $50 million funding to the National Council on Aging (NCOA), the voice for everyone’s right to age well, to launch a national effort to ensuring that older folks and people with disabilities obtain the most recent COVID and flu vaccines. The […]
Understanding Personality Disorders [Free Webinar]
24 January, 2023, | 12:00 PM – 1:00 PM CST | Online Personality describes everything about you, and personality disorders can be challenging to manage. In addition to dealing with the illness itself, people often struggle with the myths and stigma surrounding personality disorders. Explore the categories of personality disorders, […]
Biocytogen Announces FDA Clearance of IND Application for Bispecific Antibody YH008
The US FDA has approved the Investigational New Drug (IND) application for a phase I study of YH008, an internally created first-in-class PD-1 x CD40 bispecific antibody, according to a statement from Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (bsAb). Eucure Biopharma, a subsidiary of Biocytogen, finished the IND application. The YH008 […]
Carrick Therapeutics and The Menarini Group Announce Collaboration on Clinical Trials to Evaluate Samuraciclib and Elacestrant Combination
The Menarini Group, a renowned international private equity pharmaceutical company private sector, and Carrick Therapeutics, an oncology-focused biopharmaceutical company that discovers and develops highly distinct therapies, today announced a clinical trial collaboration and supply agreement. This agreement covers the conduct of a Phase 2 clinical trial to assess Carrick’s novel […]
Black Patients’ Buy-In Suffers When They Are Not Included in Drug Trials
If more Black individuals were included in drug trials, Black patients and their doctors might be more receptive to innovative treatments, according to recent research. Only 5% of volunteers in drug trials now are Black Americans. In a recent study, nearly 75% of physicians said that patients frequently inquire about […]
Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
Natural Killer Cell Therapeutics in Oncology : Sanofi and Innate Pharma SA today announced the expansion of their partnership, with Sanofi licencing an NK cell engager programme from Innate’s ANKETTM (Antibody-based NK Cell Engager Therapeutics) technology that targets B7H3. Additionally, Sanofi will have the choice to add up to two […]
Sameday Health Launches Single Swab Test for COVID-19, Flu, and RSV
Today, Sameday Health, a national testing and wellness company, announced the availability of their single swab test for respiratory syncytial virus, influenza A/B strains, and COVID-19 (RSV). This state-of-the-art medical testing technology, already available at clinics in Los Angeles with plans to go statewide shortly, provides trustworthy results, unparalleled efficiency, […]
Saluda Medical Initiates U.S. Commercialization of the Evoke® Spinal Cord Stimulation System
Evoke® Spinal Cord Stimulation System: The first and only SmartSCSTM in the United States, the Evoke® System, has begun to be sold, according to Saluda Medical Pty Limited (“Saluda Medical”), a global medical device firm redefining the field of neuromodulation. The limited commercial release (LCR) of the Evoke System in […]